SCHEMBL9682084

SCHEMBL9682084

CCc1cc(NCc2nc3c(cc2OC)CCCC3)c(=O)[nH]c1CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
POLB P06746 4/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TP53 P04637 4/20 0.34
KDM4E B2RXH2 2/20 0.34
THRB P10828 1/20 0.34
C5AR1 P21730 3/20 0.33
APAF1 O14727 1/20 0.32
RECQL P46063 1/20 0.32
SMPD3 Q9NY59 1/20 0.32
NPC1 O15118 1/20 0.32
P2RX7 Q99572 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
PPARG P37231 1/20 0.32
KMT2A Q03164 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
SLC2A1 P11166 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9681383 0.98 NPC1 (0.34) MAPTPOLBNPSR1RXFP1TP53
SCHEMBL9846183 0.87 RXFP1 (0.38) MAPTPOLBNPSR1RXFP1TP53
SCHEMBL9680321 0.86 NPSR1 (0.36) MAPTPOLBNPSR1RXFP1TP53
SCHEMBL9681437 0.84 NPSR1 (0.34) MAPTNPSR1RXFP1KDM4EAPAF1
SCHEMBL9680861 0.83 SLC2A1 (0.38) MAPTPOLBKDM4EAPAF1RECQL
SCHEMBL9680359 0.82 MAPT (0.34) MAPTKDM4EAPAF1RECQL
SCHEMBL9682064 0.82 MAPT (0.34) MAPTKDM4EAPAF1RECQLSMPD3
SCHEMBL9681442 0.80 KDM4E (0.36) MAPTKDM4EAPAF1RECQL
SCHEMBL9681915 0.79 PDE10A (0.40) MAPTKDM4EAPAF1RECQLNPC1
SCHEMBL9682808 0.78 PDE10A (0.34) MAPTPOLBKDM4ETHRBAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP claimed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed